Company · Ballsbridge, Dublin, Ireland
Endo Operations Ltd.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 10
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 33
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| FOSFOMYCIN POWDER FOR ORAL SOLUTION | 02489457 | Cancelled Pre Market | |
| METHIMAZOLE TABLETS USP | 02489716 | Cancelled Pre Market | |
| METHIMAZOLE TABLETS USP | 02489724 | Cancelled Pre Market | |
| METHIMAZOLE TABLETS USP | 02489732 | Cancelled Pre Market | |
| PMS-METHADONE | 02388383 | Cancelled Pre Market | |
| PMS-METHADONE | 02388391 | Cancelled Pre Market | |
| PMS-METHADONE | 02388405 | Cancelled Pre Market | |
| PMS-METHADONE | 02388413 | Cancelled Pre Market | |
| TEVA-FROVATRIPTAN | 02415844 | Cancelled Post Market | |
| XIAFLEX | 02388316 | Cancelled Post Market |
Notices of Compliance
Newest first.
- NUCYNTA EXTENDED-RELEASENovember 4, 2025 · NOC 36322 · Supplement to a New Drug Submission (SNDS)
- NUCYNTA IROctober 14, 2025 · NOC 36165 · Supplement to a New Drug Submission (SNDS)
- PENNSAIDMay 30, 2025 · NOC 35447 · New Drug Submission (NDS)
- TRANDATEMay 23, 2025 · NOC 35427 · New Drug Submission (NDS)
- PMS-METHADONEMay 16, 2025 · NOC 35364 · New Drug Submission (NDS)
- MUSEMay 9, 2025 · NOC 35329 · New Drug Submission (NDS)
- LOCACORTEN VIOFORM EARDROPSMay 1, 2025 · NOC 35284 · New Drug Submission (NDS)
- FLORINEFApril 30, 2025 · NOC 35277 · Supplement to a New Drug Submission (SNDS)
- METADOL-DApril 15, 2025 · NOC 35187 · New Drug Submission (NDS)
- METADOLMarch 18, 2025 · NOC 35030 · New Drug Submission (NDS)
- TAPAZOLEMarch 7, 2025 · NOC 34998 · New Drug Submission (NDS)
- SANDOMIGRAN DSMarch 5, 2025 · NOC 34957 · New Drug Submission (NDS)
- SILENORFebruary 27, 2025 · NOC 34914 · New Drug Submission (NDS)
- TRIDURALFebruary 19, 2025 · NOC 34871 · New Drug Submission (NDS)
- LOCACORTEN VIOFORMFebruary 14, 2025 · NOC 34849 · New Drug Submission (NDS)
- PENTHROXJanuary 31, 2025 · NOC 34779 · Supplement to a New Drug Submission (SNDS)
- FLORINEFDecember 31, 2024 · NOC 34637 · New Drug Submission (NDS)
- CYESTRA-35November 20, 2024 · NOC 34423 · Abbreviated New Drug Submission (ANDS)
- DEXEDRINE; DEXEDRINE SPANSULENovember 6, 2024 · NOC 34335 · New Drug Submission (NDS)
- PENTHROXOctober 22, 2024 · NOC 34245 · Supplement to a New Drug Submission (SNDS)
- XCOPRIOctober 11, 2024 · NOC 34379 · Supplement to a New Drug Submission (SNDS)
- DANTRIUM INTRAVENOUSAugust 23, 2024 · NOC 33865 · New Drug Submission (NDS)
- TRINIPATCH 0.2; TRINIPATCH 0.4; TRINIPATCH 0.6August 21, 2024 · NOC 33850 · New Drug Submission (NDS)
- MONUROLAugust 20, 2024 · NOC 33835 · New Drug Submission (NDS)
- TEVA-FROVATRIPTANAugust 9, 2024 · NOC 33788 · New Drug Submission (NDS)
- DANTRIUM CAPSULESAugust 1, 2024 · NOC 33741 · New Drug Submission (NDS)
- VEREGENJuly 19, 2024 · NOC 33684 · New Drug Submission (NDS)
- NUCYNTA IRJuly 17, 2024 · NOC 33651 · Supplement to a New Drug Submission (SNDS)
- TESTIM 1%July 11, 2024 · NOC 33620 · New Drug Submission (NDS)
- ANTIZOLJune 6, 2024 · NOC 33405 · New Drug Submission (NDS)
- FROVAJune 4, 2024 · NOC 33386 · New Drug Submission (NDS)
- ENVARSUS PAMay 17, 2024 · NOC 33241 · Supplement to a New Drug Submission (SNDS)
- XCOPRIMay 15, 2024 · NOC 33222 · Supplement to a New Drug Submission (SNDS)